Curis Inc (CRIS) stock
CRISNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.45−0.13 (-22.18%)
Close on Nov 13, 2026Market cap $930.08KP/E –Yield –
Earnings
Curis's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
Mar 18, 2027
Q4 FY2026 · estimated, during market hours
Revenue, Q3 FY2026
–
– on a year earlier
EPS, Q3 FY2026
-$1.94
-$0.49 a year earlier
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of Curis's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Mar 18, 2027Expected | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 13, 2026after the close | – | – | -$1.94 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 12, 2026during market hours | – | – | -$1.25 | Release |
| Q4 FY2025ended Dec 31, 2025 | Mar 19, 2026during market hours | $1.10M | – | $1.23 | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 6, 2025during market hours | $3.20M | +10.3% | -$0.49 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 5, 2025before the open | $2.70M | +8.0% | -$0.68 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 6, 2025before the open | $2.40M | +14.3% | -$1.25 | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 28, 2025before the open | – | – | – | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 14, 2024before the open | $2.90M | +3.6% | -$1.70 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 1, 2024before the open | $2.50M | +13.6% | -$2.03 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 7, 2024before the open | $2.10M | -8.7% | -$2.05 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 8, 2024before the open | $2.70M | -6.9% | -$2.03 | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 2, 2023before the open | $2.80M | 0.0% | -$2.13 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 3, 2023during market hours | $2.20M | -8.3% | -$0.12 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 4, 2023during market hours | $2.30M | +9.5% | -$0.12 | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 13, 2023before the open | $2.90M | -6.5% | -$0.12 | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 9, 2022during market hours | $2.80M | -6.7% | -$0.14 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 4, 2022during market hours | $2.40M | – | -$0.17 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 5, 2022during market hours | $2.10M | – | -$0.18 | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 24, 2022during market hours | $3.10M | – | -$0.15 | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 9, 2021during market hours | $3.00M | – | -$0.12 | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 3, 2021during market hours | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | May 12, 2021during market hours | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Mar 16, 2021during market hours | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Nov 10, 2020during market hours | – | – | – | Filing |
| Q2 FY2020ended Jun 30, 2020 | Aug 4, 2020during market hours | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Curis has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Curis puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Curis filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- News
- Results
- Results
- Update
- Update
- Results
- Results
- Results
- Results
- News
- Results
- News
See a number that looks wrong?